These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lipid-lowering therapy and risk of coronary events. Lardinois CK JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463 [No Abstract] [Full Text] [Related]
3. [Treatment with statins: lowering of cholesterol or more?]. Rutishauser J Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605 [No Abstract] [Full Text] [Related]
4. Stricter cholesterol guidelines broaden indications for the 'statin' drugs. Capriotti T Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600 [No Abstract] [Full Text] [Related]
5. Should every patient with diabetes receive a statin? Dembowski E; Davidson MH Pol Arch Med Wewn; 2008; 118(7-8):398-401. PubMed ID: 18714733 [No Abstract] [Full Text] [Related]
7. Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world. De Geest B; Van Linthout S Eur Heart J; 2024 Oct; 45(39):4216-4218. PubMed ID: 39217498 [No Abstract] [Full Text] [Related]
8. High HDL may not protect the heart. Concentrate on lowering LDL for now, experts advise. Harv Heart Lett; 2012 Sep; 23(1):6. PubMed ID: 23097807 [No Abstract] [Full Text] [Related]
10. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. Barter PJ; Rye KA Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953 [No Abstract] [Full Text] [Related]
13. I am 72, had a heart attack 16 years ago, and had angioplasty at Cleveland Clinic. My LDL was over 100 and HDL was in the low 30s. I take rosuvastatin and now my LDL is below 70, but my HDL has been driven down also, to 22. I am unable to raise HDL independent of LDL. Is it more important to control LDL below 70 and let HDL find its own level? Heart Advis; 2008 May; 11(5):8. PubMed ID: 18693330 [No Abstract] [Full Text] [Related]
14. [Treatment with statins for the reduction of cardiovascular risk]. Chiariello M Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779 [No Abstract] [Full Text] [Related]
15. Update on statins and other lipid-lowering drugs. Miller CA Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910 [No Abstract] [Full Text] [Related]
16. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses? Watts GF Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879 [No Abstract] [Full Text] [Related]
17. PCSK9 Inhibitors and Cardiovascular Events. Sabatine MS; Wasserman SM; Stein EA N Engl J Med; 2015 Aug; 373(8):774-5. PubMed ID: 26295078 [No Abstract] [Full Text] [Related]
18. PCSK9 Inhibitors and Cardiovascular Events. Goemann IM; Londero TM; Dora JM N Engl J Med; 2015 Aug; 373(8):773-4. PubMed ID: 26287856 [No Abstract] [Full Text] [Related]
19. Trial clouds use of niacin with a statin. Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606 [No Abstract] [Full Text] [Related]
20. Statins as cardioprotective agents. Piskur JR; Stone NJ Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325 [No Abstract] [Full Text] [Related] [Next] [New Search]